PCOS care platforms are shifting the conversation from fertility to lifelong metabolic health
Dr. Dereck Mush, MD, MBA
Signos
Offers continuous glucose monitoring paired with AI for personalized weight loss.
What they do
Signos combines continuous glucose monitors with an AI-driven mobile app to provide real-time metabolic data. The platform helps individuals track glucose spikes and receive personalized recommendations for diet and exercise to achieve healthy weight loss.
The record
- Vertical
- Metabolic Health
- Sub-segment
- Metabolic tracking
- Product type
- Platform software
- Stage
- Series B
- Headquarters
- San Mateo, USA
- Region
- North America
- Founded
- 2018
- Total funding
- $37M raised
Notable investors: Cheyenne Ventures, Dexcom Ventures, GV.
Also in Metabolic Health
Related on The Signal
Dr. Dereck Mush, MD, MBA
Inverting the GLP-1 Axis: Antagonism and the Unintended Metabolic Casualties of Bariatric Surgery
Dr. Dereck Mush, MD, MBA
Cycle tracking wearables are being asked to prove clinical grade accuracy, not just convenience
Dr. Dereck Mush, MD, MBA
Continuous glucose monitors are now a mainstream wellness product. The evidence base has not fully kept pace
Dr. Dereck Mush, MD, MBA